Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06503666 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Zambian Informed Motivated Aware Responsible Adolescent Girls and Adults

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  2. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Dec 2026 to Dec 1, 2026
    • Study completion date: May 2028 to May 1, 2028
    • Start date changed from estimate of Apr 1, 2025 to Apr 7, 2025
  3. Notable Start date: Sep 2024 to Apr 1, 2025v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The proposed hybrid effectiveness-implementation study will systematically adapt the Informed, Motivated, Aware, Responsible Adolescent Girls and Adults (IMARA) curriculum that was previously adapted for South Africa (IMARA-SA) to use in Zambia (will be renamed Zambian Informed, Motivated, Aware, Responsible Adolescent Girls and Adults (ZAIMARA) and evaluate the impact of ZAIMARA on improving adolescent girls and young women HIV testing, HIV and STI incidence, PrEP uptake and sexual risk behaviour. The study will also assess the impact of monthly mental health screening with referral versus a monthly nutrition and exercise screening on peer leaders job retention. We will also examine implementation factors and outcomes associated with ZAIMARA across five sites.
Trial Details
NCT Number NCT06503666
Lead Sponsor Centre for Infectious Disease Research in Zambia
Collaborators: University of Illinois at Chicago, University of Alabama at Birmingham
Conditions
(from sponsor)
HIV Infections, Sexually Transmitted Diseases
Related terms HIV Infections, Sexually Transmitted Diseases
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov